Platelets Are at the Nexus of Vascular Diseases
Platelets are important actors of cardiovascular diseases (CVD). Current antiplatelet drugs that inhibit platelet aggregation have been shown to be effective in CVD treatment. However, the management of bleeding complications is still an issue in vascular diseases. While platelets can act individual...
Main Authors: | Héloïse Lebas, Katia Yahiaoui, Raphaël Martos, Yacine Boulaftali |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-09-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcvm.2019.00132/full |
Similar Items
-
Changes in platelet function with inflammation in patients undergoing vascular surgery
by: Bartosz Olechowski, et al.
Published: (2019-02-01) -
Platelets, Macrophages, and Thromboinflammation in Chagas Disease
by: Choudhuri S, et al.
Published: (2022-10-01) -
Platelet-Leukocyte Interplay in Cancer Development and Progression
by: Dagmar Stoiber, et al.
Published: (2020-04-01) -
Platelet Functions During Extracorporeal Membrane Oxygenation. Platelet–Leukocyte Aggregates Analyzed by Flow Cytometry as a Promising Tool to Monitor Platelet Activation
by: Alexandre Mansour, et al.
Published: (2020-07-01) -
Aspirin nonsensitivity in patients with vascular disease: Assessment by light transmission aggregometry (aspirin nonsensitivity in vascular patients)
by: Hamzah Khan, et al.
Published: (2021-12-01)